Molecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1H-indole-3-yl)-N′-[(E)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage

Abstract Cisplatin is an efficient anticancer drug against various types of cancers however, its usage involves side effects. We investigated the mechanisms of action of indole derivative, 2-(5-methoxy-2-methyl-1H-indol-3-yl)-N'-[(E)-(3-nitrophenyl) methylidene] acetohydrazide (MMINA) against a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Suhail Razak, Tayyaba Afsar, Nousheen Bibi, Mahmoud Abulmeaty, Wajhul Qamar, Ali Almajwal, Anam Inam, Dara Al Disi, Maria Shabbir, Mashooq Ahmad Bhat
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8cdddadb299a44c6b6bde347ea84f9bd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8cdddadb299a44c6b6bde347ea84f9bd
record_format dspace
spelling oai:doaj.org-article:8cdddadb299a44c6b6bde347ea84f9bd2021-12-02T16:31:07ZMolecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1H-indole-3-yl)-N′-[(E)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage10.1038/s41598-021-84748-y2045-2322https://doaj.org/article/8cdddadb299a44c6b6bde347ea84f9bd2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-84748-yhttps://doaj.org/toc/2045-2322Abstract Cisplatin is an efficient anticancer drug against various types of cancers however, its usage involves side effects. We investigated the mechanisms of action of indole derivative, 2-(5-methoxy-2-methyl-1H-indol-3-yl)-N'-[(E)-(3-nitrophenyl) methylidene] acetohydrazide (MMINA) against anticancer drug (cisplatin) induced organ damage using a rodent model. MMINA treatment reversed Cisplatin-induced NO and malondialdehyde (MDA) augmentation while boosted the activity of glutathione peroxidase (GPx), and superoxide dismutase (SOD). The animals were divided into five groups (n = 7). Group1: Control (Normal) group, Group 2: DMSO group, Group 3: cisplatin group, Group 4: cisplatin + MMINA group, Group 5: MMINA group. MMINA treatment normalized plasma levels of biochemical enzymes. We observed a significant decrease in CD4+COX-2, STAT3, and TNF-α cell population in whole blood after MMINA dosage. MMINA downregulated the expression of various signal transduction pathways regulating the genes involved in inflammation i.e. NF-κB, STAT-3, IL-1, COX-2, iNOS, and TNF-α. The protein expression of these regulatory factors was also downregulated in the liver, kidney, heart, and brain. In silico docking and dynamic simulations data were in agreement with the experimental findings. The physiochemical properties of MMINA predicted it as a good drug-like molecule and its mechanism of action is predictably through inhibition of ROS and inflammation.Suhail RazakTayyaba AfsarNousheen BibiMahmoud AbulmeatyWajhul QamarAli AlmajwalAnam InamDara Al DisiMaria ShabbirMashooq Ahmad BhatNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-23 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Suhail Razak
Tayyaba Afsar
Nousheen Bibi
Mahmoud Abulmeaty
Wajhul Qamar
Ali Almajwal
Anam Inam
Dara Al Disi
Maria Shabbir
Mashooq Ahmad Bhat
Molecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1H-indole-3-yl)-N′-[(E)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage
description Abstract Cisplatin is an efficient anticancer drug against various types of cancers however, its usage involves side effects. We investigated the mechanisms of action of indole derivative, 2-(5-methoxy-2-methyl-1H-indol-3-yl)-N'-[(E)-(3-nitrophenyl) methylidene] acetohydrazide (MMINA) against anticancer drug (cisplatin) induced organ damage using a rodent model. MMINA treatment reversed Cisplatin-induced NO and malondialdehyde (MDA) augmentation while boosted the activity of glutathione peroxidase (GPx), and superoxide dismutase (SOD). The animals were divided into five groups (n = 7). Group1: Control (Normal) group, Group 2: DMSO group, Group 3: cisplatin group, Group 4: cisplatin + MMINA group, Group 5: MMINA group. MMINA treatment normalized plasma levels of biochemical enzymes. We observed a significant decrease in CD4+COX-2, STAT3, and TNF-α cell population in whole blood after MMINA dosage. MMINA downregulated the expression of various signal transduction pathways regulating the genes involved in inflammation i.e. NF-κB, STAT-3, IL-1, COX-2, iNOS, and TNF-α. The protein expression of these regulatory factors was also downregulated in the liver, kidney, heart, and brain. In silico docking and dynamic simulations data were in agreement with the experimental findings. The physiochemical properties of MMINA predicted it as a good drug-like molecule and its mechanism of action is predictably through inhibition of ROS and inflammation.
format article
author Suhail Razak
Tayyaba Afsar
Nousheen Bibi
Mahmoud Abulmeaty
Wajhul Qamar
Ali Almajwal
Anam Inam
Dara Al Disi
Maria Shabbir
Mashooq Ahmad Bhat
author_facet Suhail Razak
Tayyaba Afsar
Nousheen Bibi
Mahmoud Abulmeaty
Wajhul Qamar
Ali Almajwal
Anam Inam
Dara Al Disi
Maria Shabbir
Mashooq Ahmad Bhat
author_sort Suhail Razak
title Molecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1H-indole-3-yl)-N′-[(E)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage
title_short Molecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1H-indole-3-yl)-N′-[(E)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage
title_full Molecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1H-indole-3-yl)-N′-[(E)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage
title_fullStr Molecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1H-indole-3-yl)-N′-[(E)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage
title_full_unstemmed Molecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1H-indole-3-yl)-N′-[(E)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage
title_sort molecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1h-indole-3-yl)-n′-[(e)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/8cdddadb299a44c6b6bde347ea84f9bd
work_keys_str_mv AT suhailrazak moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage
AT tayyabaafsar moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage
AT nousheenbibi moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage
AT mahmoudabulmeaty moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage
AT wajhulqamar moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage
AT alialmajwal moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage
AT anaminam moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage
AT daraaldisi moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage
AT mariashabbir moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage
AT mashooqahmadbhat moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage
_version_ 1718383886671544320